✦ LIBER ✦

Impact of clinical syndrome acuity on the differential response to 2 glycoprotein IIb/IIIa inhibitors in patients undergoing coronary stenting. The TARGET trial

✍ Scribed by G.W. Stone; D.J. Moliterno; M. Bertrand

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Impact of clinical syndrome acuity on th

✍ Gregg W. Stone; David J. Moliterno; Michel Bertrand; Franz-Joseph Neumann; Howar 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 144 KB

TCT-472: Impact of Different Glycoprotei

📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 215 KB

Comparison of Bivalirudin Versus Bivalir

✍ Dinesh Kumar; George Dangas; Roxana Mehran; Ajay Kirtane; Michel Bertrand; Ramin 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 152 KB

The Effect of Glycoprotein IIb/IIIa Rece

✍ Philip Wong; Scott Harding; Ignacio Inglessis; C. Joon Choi; Darren Walters; Yuc 📂 Article 📅 2003 🏛 Springer US 🌐 English ⚖ 90 KB

Safety and Efficacy of Bivalirudin With

✍ Harvey D. White; E. Magnus Ohman; A. Michael Lincoff; Michel E. Bertrand; Antoni 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 571 KB

878-3 Subgroup analysis of the impact of

✍ Peter B Berger; Adnan Kastrati; Julinda Mehilli; Helmut Schuhlen; Josef Dirschin 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 66 KB